Cure Pharmaceutical: Funding, Investors & Team (Sep 2026)
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin films on the market today. CURE is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and Germany, among other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.
Cure Pharmaceutical has raised $630k across 1 funding round on record, the most recent a Debt Financing of $630k announced in Sep 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cure Pharmaceutical Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Cure Pharmaceutical Funding Rounds
Cure Pharmaceutical Founders and Leadership Team
No contact details are on record for this team yet.
Cure Pharmaceutical Funding Compared to Other Biotechnology Startups
Cure Pharmaceutical's latest round of $630k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cure Pharmaceutical in Biotechnology and Oxnard
Companies Similar to Cure Pharmaceutical
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Cure Pharmaceutical Funding FAQs
What does Cure Pharmaceutical do?
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin films on the market today. CURE is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and Germany, among other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.
How much funding has Cure Pharmaceutical raised?
Cure Pharmaceutical has raised $630k across 1 round on record. The most recent is a Debt Financing of $630k announced in Sep 2022.
When did Cure Pharmaceutical last raise funding?
Cure Pharmaceutical's most recent funding round on record is a Debt Financing of $630k, announced in Sep 2022.
Who is the CEO of Cure Pharmaceutical?
Isaac Kwabena Adjei is listed as CEO at Cure Pharmaceutical.
Where is Cure Pharmaceutical headquartered?
Cure Pharmaceutical is based in Oxnard, California, United States.
How many employees does Cure Pharmaceutical have?
Cure Pharmaceutical is in the 51-100 employee band.
How does Cure Pharmaceutical's funding compare to other Biotechnology startups?
Cure Pharmaceutical's latest round of $630k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Cure Pharmaceutical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cure Pharmaceutical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.